Exemestane is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Cadila Healthcare Limited. The primary component is Exemestane.
Product ID | 70771-1374_2301b37f-ea7b-4462-9a2d-196a2e2b042a |
NDC | 70771-1374 |
Product Type | Human Prescription Drug |
Proprietary Name | Exemestane |
Generic Name | Exemestane |
Dosage Form | Tablet |
Route of Administration | ORAL |
Marketing Start Date | 2018-10-08 |
Marketing Category | ANDA / ANDA |
Application Number | ANDA202602 |
Labeler Name | Cadila Healthcare Limited |
Substance Name | EXEMESTANE |
Active Ingredient Strength | 25 mg/1 |
Pharm Classes | Aromatase Inhibitor [EPC],Aromatase Inhibitors [MoA] |
NDC Exclude Flag | N |
Listing Certified Through | 2020-12-31 |
Marketing Start Date | 2018-10-08 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | ANDA |
Application Number | ANDA202602 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2018-10-08 |
Ingredient | Strength |
---|---|
EXEMESTANE | 25 mg/1 |
SPL SET ID: | fab5468a-d5b7-45e3-b8b2-ed902fddd3a6 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI | |
UPC Code |
NDC | Brand Name | Generic Name |
---|---|---|
0054-0080 | Exemestane | Exemestane |
0378-5001 | Exemestane | exemestane |
0832-0595 | Exemestane | Exemestane |
44278-025 | Exemestane | EXEMESTANE |
47781-108 | Exemestane | Exemestane |
50090-5193 | Exemestane | Exemestane |
51991-005 | Exemestane | Exemestane |
59651-516 | Exemestane | Exemestane |
59762-2858 | EXEMESTANE | Exemestane |
63629-2056 | Exemestane | Exemestane |
65162-240 | Exemestane | Exemestane |
68382-383 | Exemestane | Exemestane |
69097-316 | EXEMESTANE | exemestane |
70771-1374 | Exemestane | Exemestane |
71921-190 | Exemestane | Exemestane |
0009-7663 | Aromasin | exemestane |